Fibrosis is a central component of numerous major diseases and is implicated in an estimated 45% of all deaths in the developed world. Hallmarks of fibrosis include myofibroblast (MF) induction, excessive MF proliferation and matrix synthesis, and stiffening or contraction of the extracellular matrix (ECM), but how these changes are interrelated and feedback to reinforce the fibrotic process is not understood. This is in part because we lack a fundamental understanding of how cells sense, mechanically respond to, and in turn alter the structure and mechanics of their surroundings during fibrosis. To fill ths gap in our knowledge and develop treatments that target the mechanisms of fibrosis, we need experimental platforms that allow us to 1) accurately capture the fibrous structure and mechanical behavior of tissues, and 2) monitor the mechanical forces that drive MF differentiation, proliferation, and subsequent fibrotic stiffening. The overall focus of the proposd work is to connect intracellular and extracellular mechanics during the initiation (K99) and reinforcement (R00) of MF induction and proliferation. During the K99 phase, we will develop a technique to measure traction forces in a newly established synthetic ECM that is fibrous, mechanically tunable, and can be reorganized by cells. Using this platform, we will examine whether TGF- induces RhoA-mediated fibril reorganization to increase traction force generation and subsequent MF induction and proliferation. With an understanding of how MF induction and proliferation is initiated, we will go on to examine how increased MF cell density reinforces fibrotic changes during the R00 phase. We will determine whether tension within the fibrillar ECM generated by high densities of contractile MFs spurs further MF induction. Next, we will examine the effect of high MF density on fibrillar network stiffening via ECM synthesis, and query whether this in turn also promotes MF induction. To understand the interplay between the physical surroundings of the cell, intracellular signaling, and cellular traction generation, this work will rely on biomaterial engineering, molecular biology, and finite element modeling approaches. While the applicant has significant experience in biomaterial development and has already established the synthetic fibrillar ECM to be employed in the proposed studies, he requires further training in myofibroblast biology, mechanical modeling, and the development of traction force measurements. The support and training provided by both this award and the assembled mentoring team will grant the applicant tools and expertise critical to his future independent research program. Additionally, this work will shine light on biophysical mechanisms common to fibrotic changes accompanying numerous diseases, and will provide a test bed for therapeutics that can disrupt this process.

Public Health Relevance

During fibrosis, abnormal myofibroblasts impair organ function by stiffening tissues, but how tissue stiffening causes healthy cells to become myofibroblasts is not understood. This is in part due to the need for appropriate models that 1) mimic the fibrous structure of tissues and 2) allow us to monitor the mechanical forces that underlie myofibroblast transformation and tissue stiffening. Therefore, the proposed work will develop cell force measurements in a synthetic fibrous tissue model to study the mechanics of myofibroblast transformation, with the long term goal of establishing a test bed for therapeutics that target this process to stop fibrosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Career Transition Award (K99)
Project #
1K99HL124322-01A1
Application #
8891850
Study Section
NHLBI Mentored Transition to Independence Review Committee (MTI)
Program Officer
Carlson, Drew E
Project Start
2015-05-12
Project End
2017-04-30
Budget Start
2015-05-12
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Boston University
Department
Engineering (All Types)
Type
Biomed Engr/Col Engr/Engr Sta
DUNS #
049435266
City
Boston
State
MA
Country
United States
Zip Code
Toyama, Tetsuo; Looney, Agnieszka P; Baker, Brendon M et al. (2018) Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis. J Invest Dermatol 138:78-88
Cao, Xuan; Ban, Ehsan; Baker, Brendon M et al. (2017) Multiscale model predicts increasing focal adhesion size with decreasing stiffness in fibrous matrices. Proc Natl Acad Sci U S A 114:E4549-E4555
Heo, Su-Jin; Driscoll, Tristan P; Thorpe, Stephen D et al. (2016) Differentiation alters stem cell nuclear architecture, mechanics, and mechano-sensitivity. Elife 5:
Baker, Brendon M; Trappmann, Britta; Wang, William Y et al. (2015) Cell-mediated fibre recruitment drives extracellular matrix mechanosensing in engineered fibrillar microenvironments. Nat Mater 14:1262-8